Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-815,114
Closed -$24.7M 406
2016
Q1
$24.7M Buy
815,114
+170,064
+26% +$4.67M 0.25% 116
2015
Q4
$20.5M Buy
645,050
+124,058
+24% +$4.15M 0.18% 112
2015
Q3
$15.3M Sell
520,992
-168,742
-24% -$5.7M 0.14% 174
2015
Q2
$27M Buy
689,734
+50,878
+8% +$1.99M 0.22% 133
2015
Q1
$23.9M Buy
+638,856
New +$24.3M 0.23% 128
2014
Q1
Sell
-15,498
Closed -$548K 441
2013
Q4
$548K Buy
+15,498
New +$493K 0.01% 323

Other funds holding AVNT

UBS O'Connor's AVNT Position: Q2 2016 in Review

UBS O'Connor sold out of Avient (AVNT) in Q2 2016, closing a stake of 815,114 shares — an estimated $24.7M sold.

UBS O'Connor first reported a position in AVNT in Q4 2013 and held it in 6 quarters. The position peaked at $27M in Q2 2015. 255 funds tracked by Wall St. Rank hold AVNT as of Q2 2016.

  • UBS O'Connor reported no remaining Avient position as of Q2 2016 after selling out during the quarter.
  • UBS O'Connor sold 815,114 Avient shares in Q2 2016, an estimated $24.7M.
  • UBS O'Connor first reported a position in Avient in Q4 2013 and held it in 6 quarters.
  • UBS O'Connor's Avient position peaked at $27M in Q2 2015.
  • 255 funds tracked by Wall St. Rank held Avient as of Q2 2016.

Based on UBS O'Connor's 13F filing for Q2 2016, filed 12 Aug 2016.